The FDA announced on July 1, 2020, that Preferred Pharmaceuticals, Inc. voluntarily recalled Lidothol Patch Lidocaine Menthol due to current good manufacturing practice (CGMP) deviations. The company initiated the recall after a contract manufacturer misplaced batch records and test results for the affected lots.
How to tell if you have it
- Brand: Lidothol
- Product: Lidothol Patch Lidocaine Menthol
- Description: Lidocaine 4.5% & Menthol 5%, 15 patches per box
- Insurance NDC: 53225-1025-01
- Prod # (NDC): 68788-7405-01
- Lot Numbers: H0218Z, H1518J, I2018L, J2918C, L1018Q, A0419M, G0519G
- Expiration Date: 5/31/2021
The hazard
The recall stems from CGMP deviations where a contract manufacturing organization misplaced or lost batch records and test results for the recalled batch. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Preferred Pharmaceuticals, Inc. has 32 other recalls on record since August 15, 2018. Other recent recalls by the brand include Lidocaine Ointment (September 28, 2026), Geri-Care Eye Drops (March 25, 2026), and Ondansetron ODT (November 17, 2025). Other recent recalls of similar products include Wells Pharma Fentanyl Citrate Injectable Solution (April 1, 2026), Pro N: 5% Lidocaine Tattoo Numbing Spray (February 2, 2026), and Blossom Pharmaceuticals Globe Clotrimazole Cream (October 31, 2025).